These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 10223907)

  • 1. Aminoglycosides: nephrotoxicity.
    Mingeot-Leclercq MP; Tulkens PM
    Antimicrob Agents Chemother; 1999 May; 43(5):1003-12. PubMed ID: 10223907
    [No Abstract]   [Full Text] [Related]  

  • 2. Aminoglycoside nephrotoxicity: recent insights and perspectives.
    Tulkens PM
    Contrib Nephrol; 1984; 42():168-81. PubMed ID: 6398193
    [No Abstract]   [Full Text] [Related]  

  • 3. Aminoglycoside-induced renal phospholipidosis and nephrotoxicity.
    Laurent G; Kishore BK; Tulkens PM
    Biochem Pharmacol; 1990 Dec; 40(11):2383-92. PubMed ID: 2268362
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular aspects of renal handling of aminoglycosides and strategies for preventing the nephrotoxicity.
    Nagai J; Takano M
    Drug Metab Pharmacokinet; 2004 Jun; 19(3):159-70. PubMed ID: 15499183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoglycoside nephrotoxicity: do time and frequency of administration matter?
    Beauchamp D; Labrecque G
    Curr Opin Crit Care; 2001 Dec; 7(6):401-8. PubMed ID: 11805542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrotoxicity of aminoglycosides. Effects on pharmacokinetics and prevention.
    Brogard JM; Comte F; Spach MO
    Contrib Nephrol; 1984; 42():182-95. PubMed ID: 6398194
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction of aminoglycosides and cephaloridine in the rabbit kidney.
    Dolislager D; Fravert D; Tune BM
    Res Commun Chem Pathol Pharmacol; 1979 Oct; 26(1):13-23. PubMed ID: 515499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental studies on nephrotoxicity of aminoglycosides at low doses. Mechanisms and perspectives.
    Tulkens PM
    Am J Med; 1986 Jun; 80(6B):105-14. PubMed ID: 3728522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, nephrotoxicity and ototoxicity of aminoglycosides, mathematically modelled for modelling-supported therapeutic drug monitoring.
    Croes S; Koop AH; van Gils SA; Neef C
    Eur J Pharm Sci; 2012 Jan; 45(1-2):90-100. PubMed ID: 22094306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new aminoglycoside etimicin shows low nephrotoxicity and ototoxicity in zebrafish embryos.
    Shao W; Zhong D; Jiang H; Han Y; Yin Y; Li R; Qian X; Chen D; Jing L
    J Appl Toxicol; 2021 Jul; 41(7):1063-1075. PubMed ID: 33094525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetic interpretation of the nephrotoxic effect of aminoglycosides. Pharmacokinetic aspects of nephrotoxicity of aminoglycosides].
    Firsov AA; Gagaeva EV
    Antibiot Khimioter; 1989 Feb; 34(2):148-53. PubMed ID: 2658891
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of kidney epithelial cell line (LLC-PK1) to study aminoglycoside nephrotoxicity.
    Inui K; Saito H; Hori R
    Dev Toxicol Environ Sci; 1986; 14():217-26. PubMed ID: 2881770
    [No Abstract]   [Full Text] [Related]  

  • 13. Aminoglycosides induce a phospholipidosis in the renal cortex of the rat: an early manifestation of nephrotoxicity.
    Feldman S; Wang MY; Kaloyanides GJ
    J Pharmacol Exp Ther; 1982 Mar; 220(3):514-20. PubMed ID: 7062263
    [No Abstract]   [Full Text] [Related]  

  • 14. Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk.
    Boyer A; Gruson D; Bouchet S; Clouzeau B; Hoang-Nam B; Vargas F; Gilles H; Molimard M; Rogues AM; Moore N
    Drug Saf; 2013 Apr; 36(4):217-30. PubMed ID: 23508544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choice of drug and dosage regimen. Two important risk factors for aminoglycoside nephrotoxicity.
    De Broe ME; Giuliano RA; Verpooten GA
    Am J Med; 1986 Jun; 80(6B):115-8. PubMed ID: 3728523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular parameters involved in aminoglycoside nephrotoxicity.
    Mingeot-Leclercq MP; Brasseur R; Schanck A
    J Toxicol Environ Health; 1995 Mar; 44(3):263-300. PubMed ID: 7897692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nephrotoxicity and renal accumulation of amikacin, tobramycin and gentamycin in rats, rabbits and guinea pigs.
    Sairio E; Kasanen A; Kangas L; Nieminen AL; Nieminen L
    Exp Pathol (Jena); 1978; 15(6):370-5. PubMed ID: 744211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminoglycoside accumulation kinetics in rat renal parenchyma.
    Aronoff GR; Pottratz ST; Brier ME; Walker NE; Fineberg NS; Glant MD; Luft FC
    Antimicrob Agents Chemother; 1983 Jan; 23(1):74-8. PubMed ID: 6830211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The area under the effect-time curve as a target parameter for dosage adaptation in renal insufficiency.
    Czock D; Keller F
    Nephrol Dial Transplant; 1999; 14 Suppl 4():4. PubMed ID: 10463186
    [No Abstract]   [Full Text] [Related]  

  • 20. The nephrotoxicity of antimicrobial agents (second of three parts).
    Appel GB; Neu HC
    N Engl J Med; 1977 Mar; 296(13):722-8. PubMed ID: 190540
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 27.